Geron Corp. GERN

NAS: GERN | ISIN: US3741631036   26/12/2025
1,370 USD (-2,14%)
(-2,14%)   26/12/2025
Grafiek Geron Corp. Grafiek Geron Corp.

Geron Corp. in het nieuws

4 december 2025 · Blood Cancer Therapeutics Reach Critical Commercial and Clinical Inflection Points · Persbericht

9 mei 2025 · Contact Levi & Korsinsky by May 12, 2025 Deadline to Join Class Action Against Geron Corporation(GERN) · Persbericht

6 mei 2025 · INVESTOR DEADLINE NEXT WEEK: Geron Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GERN · Persbericht

6 mei 2025 · Geron Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before May 12, 2025 to Discuss Your Rights - GERN · Persbericht

2 mei 2025 · Levi & Korsinsky Reminds Geron Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 12, 2025 - GERN · Persbericht

27 april 2025 · Faruqi & Faruqi Reminds Geron Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 12, 2025 - GERN · Persbericht

26 april 2025 · GERN INVESTOR NOTICE: Geron Corporation Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit · Persbericht

25 april 2025 · Investors who lost money on Geron Corporation(GERN) should contact Levi & Korsinsky about pending Class Action - GERN · Persbericht

22 april 2025 · Levi & Korsinsky Notifies Geron Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - GERN · Persbericht

18 april 2025 · Kessler Topaz Meltzer & Check, LLP Notifies Geron Corporation Investors of Upcoming Deadline in Securities Fraud Class Action Lawsuit · Persbericht

Profiel Geron Corp.

Biotechnologie
Fabricage van farmaceutische preparaten
Gezondheidstechnologie
Productie

Website: www.geron.com

Hoofdzetel: Foster City, California vlag Verenigde Staten

Mijn selecties